Christine Ann Fox, Chief Financial Officer at Mereo BioPharma Group plc (MREO), sold 47,444 shares at $4.22 ($202K) on 2024-09-13, disclosed to the SEC on 2024-09-16.
Open-market sale of $202k MREO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.47 | 9,128 | $41K | 20.1% |
| 2 | $4.22 | 19,158 | $81K | 39.9% |
| 3 | $4.22 | 19,158 | $81K | 39.9% |
| Total | $4.27 avg | 47,444 | $202K | 100% |